Twinbeech Capital LP Danaher Corp Transaction History

Twinbeech Capital LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$224.58 - $256.19 $2.16 Million - $2.46 Million	9,613 Added 21.61%	54,106 $13.5 Million
Q4 2023 Feb 14, 2024	BUY	$185.1 - $233.13 $8.24 Million - $10.4 Million	44,493 New	44,493 $10.3 Million
Q4 2022 Feb 14, 2023	SELL	$241.42 - $282.29 $815,758 - $953,857	-3,379 Reduced 26.86%	9,199 $2.44 Million
Q3 2022 Nov 14, 2022	SELL	$247.06 - $1507.4 $20.8 Million - $127 Million	-84,064 Reduced 86.98%	12,578 $3.25 Million
Q2 2022 Aug 15, 2022	BUY	$237.11 - $299.66 $22.9 Million - $29 Million	96,642 New	96,642 $24.5 Million
Q1 2022 May 16, 2022	SELL	$257.27 - $315.76 $17.3 Million - $21.3 Million	-67,332 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $19.7 Million - $22.2 Million	67,332 New	67,332 $22.2 Million
Q2 2021 Aug 16, 2021	SELL	$225.08 - $271.69 $6.54 Million - $7.89 Million	-29,050 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$212.38 - $245.9 $4.44 Million - $5.14 Million	20,912 Added 256.97%	29,050 $6.54 Million
Q4 2020 Feb 16, 2021	BUY	$212.5 - $245.46 $1.73 Million - $2 Million	8,138 New	8,138 $1.81 Million

2,511

540M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.